Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with β-blockade or verapamil.

@article{Sherrid2013TreatmentOO,
  title={Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with β-blockade or verapamil.},
  author={Mark V Sherrid and Aneesha A Shetty and Glenda Winson and Bette Kim and Dan L. Musat and Carlos L. Alviar and Peter Homel and Sandhya K. Balaram and Daniel G. Swistel},
  journal={Circulation. Heart failure},
  year={2013},
  volume={6 4},
  pages={694-702}
}
BACKGROUND There is controversy about preferred methods to relieve obstruction in hypertrophic cardiomyopathy patients still symptomatic after β-blockade or verapamil. METHODS AND RESULTS Of 737 patients prospectively registered at our institution, 299 (41%) required further therapy for obstruction for limiting symptoms, rest gradient 61 ± 45, provoked gradient 115 ± 49 mm Hg, and followed up for 4.8 years. Disopyramide was added in 221 (74%) patients and pharmacological control of symptoms… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

Drug Therapy for Hypertrophic Cardiomypathy: Physiology and Practice

Current cardiology reviews • 2016
View 5 Excerpts
Highly Influenced

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology • 2016

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Symptomatic exercise-induced left ventricular outflow tract obstruction without left ventricular hypertrophy.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography • 2013

Alcohol septal by gest on N ovem er 6, 2017 http://circheure.ahajournals.org/ D ow nladed from 18 ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter

SF Nagueh, BM Groves, +11 authors 3rd
2011

Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: A word of caution

FJ ten Cate, OI Soliman, +4 authors PW. Serruys
Circ Heart Fail • 2010

Similar Papers

Loading similar papers…